Literature DB >> 7280716

Chemotherapy in the treatment of malignant mesothelioma.

J Aisner, P H Wiernik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7280716

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  13 in total

1.  Pleural mesothelioma treated by fast neutron therapy.

Authors:  P R Blake; M Catterall; P A Emerson
Journal:  Thorax       Date:  1985-01       Impact factor: 9.139

2.  A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study.

Authors:  E A Eisenhauer; W K Evans; N Murray; W Kocha; R Wierzbicki; K Wilson
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

3.  [Pleural mesothelioma--problems in diagnosis and clinical course in 25 patients].

Authors:  F Liewald; L Sunder-Plassmann; H Dienemann; J Mezger
Journal:  Langenbecks Arch Chir       Date:  1989

4.  Chemosensitivity and cytokine sensitivity of malignant mesothelioma.

Authors:  R V Bowman; L S Manning; M R Davis; B W Robinson
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Menogaril in the treatment of malignant mesothelioma: a phase II study.

Authors:  C A Hudis; D P Kelsen
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

6.  Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases.

Authors:  M Tani; H Tanimura; H Yamaue; S Mizobata; M Yamamoto; M Iwahashi; K Ura; Y Nagai; T Tsunoda; H Wakasaki; K Nanjo; K Fujino; S Yukawa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 7.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

8.  A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma.

Authors:  B M Cantwell; C R Franks; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma.

Authors:  E K Mbidde; S J Harland; A H Calvert; I E Smith
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Effects of natural interferon alpha, natural tumor necrosis factor alpha and their combination on human mesothelioma xenografts in nude mice.

Authors:  T Ohnuma; L Szrajer; J F Holland; M Kurimoto; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.